High-throughput tissue microarray analysis of erbB-2 gene amplification in urinary bladder cancer: A study of Bulgarian patients

Urologia Internationalis

Volumn 71, Issue 4, 2003, Pages 408-411

  Toncheva, Draga I ^a   Zaharieva, Boriana M ^a   Bassi, Pierfrancesco ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b Medical University Sofia ^*

Author keywords

Bladder cancer; ErbB 2 amplification; FISH; Tissue microarray

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA MICROARRAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE CLUSTER; GENE FREQUENCY; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BULGARIA; FEMALE; GENES, ERBB-2; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 0345602161     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074095     Document Type: Article

References (33)

1. Vogel CL, Cobleigh MA, Tripethy D: Superior outcomes with Herceptin (Trastuzumab) in fluorescence in situ hybridization (FISH) selected patients (abstract). ASCO 2001:86.
2. Mass R, Press MF, Anderson S: Improved survival benefit from Herceptin (Trastuzumab) and chemotherapy in patients selected by fluorescence in situ hybridization (FISH) (abstract). ASCO 2001:85.
3. Pauletti G, Dandekar S, Rong H, Ramos L, Peng H, Seshadri R, Slamon DJ: Assesment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: A direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol 2000;18:3651-3654.
4. Sauter G, Feichter G, Torhorst J, Moch H, Novotna H, Wagner U, Durmuller U, Waldman FM: Fluorescence in situ hybridization for detecting erbB2 amplification in breast tumor fine needle aspiration biopsies. Acta Cytol 1996;40:164-173.
5. Richter J, Beffa L, Wagner U, Schraml P, Gasser T, Moch H, Mihatsch M, Sauter G: Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am J Pathol 1998;153: 1615-1621.
6. Simon R, Burger H, Brinkschmidt C, Bocker W, Hertle L, Terpe HJ: Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol 1998;185: 345-351.
7. Richter J, Wagner U, Schraml P, Maurer R, Alund G, Knonagel H, Moch H, Mihatsch M, Gasser T, Sauter G: Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer. Cancer Res 1999;59:5687-5691.
8. Vooter C, Joos S, Bringuer P, Vallinga M, Poddighe P, Schalken J, du Manoir S, Ramaekers F, Lichter P, Hopman A: Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am J Pathol 1995;146:1341-1354.
9. Hovey R, Chu L, Balazs M, DeVries S, Moore D, Sauter G, Caroll P, Waldman F: Genetic alterations in primary bladder cancers and their metastases. Cancer Res 1998;58:3555-3560.
10. Richter J, Feng J, Gorog J, Gideon S, Egenter C, Gasser T, Moch H, Mihatsch M, Sauter G: Marked differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 1997;57:2860-2864.
11. Kallioniemi A, Kallioniemi OP, Citro G, Sauter G, DeVries S, Kerschhmann R, Carroll P, Waldman F: Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer 1995;12:213-219.
12. Zaharieva B, Damianov Ch, Tabakov V, Tzingilev B, Nikolov I, Georgiev CH, Toncheva D: Comparative genomic hybridization study of invasive transitional cell carcinomas of the urinary bladder of Bulgarian patients. Balkan J Med Genet 2002; in press.
13. Miyamoto H, Kubota Y, Noguchi S, Takase K, Matsuzaki J, Moriyam M, Takebayashi S, Kitamura H, Hasaka M: C-ERBB2 gene amplification as a prognostic marker in human bladder cancer. Urology 2000;55:679-683.
14. Lonn U, Lonn S, Friberg S, Nilsson B, Silversward C, Stenkvist B: Prognostic value of amplification of c-erb-B2 in bladder carcinoma. Clin Cancer Res 1995;1:1189-1194.
15. Orlando C, Sestini R, Vona G, Pinzani P, Bianchi S, Giacca M, Pazzagli M, Selli C: Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique. J Urol 1996;156:2089-2093.
16. Ohta JI, Miyoshi Y, Uemura H, Fujinami K, Mikata K, Hosaka M, Tokita Y, Kubota Y: Fluorescence in situ hybridization evaluation of c-erbB-2 gene amplification and chromosomal anomalies in bladder cancer. Clin Cancer Res 2001;7:2463-2467.
17. Sauter G, Moch H, Moore D, Carroll P, Kerschmann R, Chew K, Mihatsch MJ, Gudat F, Waldman F: Heterogeneity of erbB-2 amplification in bladder cancer. Cancer Res 1993; 53:2199-2203.
18. Schraml P, Kononen J, Bubendorf L, Moch H, Bissig H, Nocito A, Mihatsch MJ, Kallioniemi OP, Sauter G: Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 1999;5:1966-1975.
19. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4: 844-847.
20. Toncheva D, Zaharieva B, Todorov T, Georgiev CH: New developments of oncogenetics -high throughput tissue microarray technology. Biotechnol Biotechnol Eq 2002;2:59-64.
21. Mostofi F, Sobin L, Torloni H: Histological Typing of Urinary Bladder Tumors. International Classification of Tumors. No 10, vol 10. Geneva, World Health Organization, 1973.
22. UICC TNM Classification of Malignant Tumors, ed 4. Berlin, Springer, 1992.
23. Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, Willi N, Mihatsch MJ, Sauter G, Kallioniemi OP: Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res 1999;59:1388.
24. Moch H, Kononen T, Kallioniemi OP, Sauter G: Tissue microarrays: What will they bring to molecular and anatomic pathology? Adv Anat Pathol 2001;8:14-20.
25. Kallioniemi OP, Wagner U, Kononen J, Sauter G: Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 2001;10:657-662.
26. Nocito A, Bubendorf L, Maria, Tinner E, Suess K, Wagner U, Forster T, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Anabitarte M, Hering F, Hardmeier T, Schoenenberger AJ, Flury R, Jager P, Luc, Fehr J, Schraml P, Moch H, Mihatsch MJ, Gasser T, Sauter G: Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 2001;194:349-357.
27. Simon R, Richter J, Wagner U, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Anabitarte M, Hering F, Hardmeier T, Schonenberger A, Flury R, Jager P, Fehr JL, Schraml P, Moch H, Mihatsch MJ, Gasser T, Sauter G: High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res 2001;61:4514-4519.
28. Nocito A, Kononen J, Kallioniemi OP, Sauter G: Tissue microarrays (TMAs) for high-throughput molecular pathology research. Int J Cancer 2001;94:1-5.
29. Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Kochli OR, Mross F, Dieterich H, Moch H, Mihatsch M, Kallioniemi OP, Sauter G: Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001;159:2249-2256.
30. Bubendorf L, Nocito A, Moch H, Sauter G: Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 2001;195:72-79.
31. Mousses S, Bubendorf L, Wagner U, Hostetter G, Kononen J, Cornelison R, Goldberger N, Elkahloun AG, Willi N, Koivisto P, Ferhle W, Raffeld M, Sauter G, Kallioniemi OP: Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res 2002;62:1256-1260.
32. Richter J, Wagner U, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Anabitarte M, Hering F, Hardmeier T, Schonenberger A, Flury R, Jager P, Luc Fehr J, Schraml P, Moch H, Mihatsch MJ, Gasser T, Kallioniemi OP, Sauter G: High-throughput tissue microarray analysis of cyclin E gene amplification and overstatement in urinary bladder cancer. Am J Pathol 2000;157:787-794.
33. Simon R, Struckmann K, Schraml P, Wagner U, Forster T, Moch H, Fijan A, Bruderer J, Wilber K, Mihatsch MJ, Gasser T, Sauter G: Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene 2002;21:2476-2483.